To choose the concentration of use of the compounds, we first exposed the astrocyte cultures to different concentrations of MG, FC, LPS or STZ and evaluated the level of GFAP and S100B, which are frequently associated with brain disorders [9,60]. This evidence concerns the gene S100B and brain disorder.